Skip to main content
Top

Medical Microbiology and Immunology

Issue 1/2002

Content (8 Articles)

Original Investigation

Culture filtrate antigens and allergens of Epicoccum nigrum cultivated in modified semi-synthetic medium

Vandana Bisht, Bhanu Singh, Raj Kumar, Naveen Arora, Susheela Sridhara

Original Investigation

Virolytic action of lipoprotein lipase on hepatitis C virus in human sera

Reiner Thomssen, Sigrid Bonk

Original Investigation

Asialo-GM1 and asialo-GM2 are putative adhesion molecules for Moraxella catarrhalis

Kamruddin Ahmed, Yasuo Suzuki, Daisei Miyamoto, Tsuyoshi Nagatake

Review

Role of influenza A virus hemagglutinin in neurovirulence for mammalians

Isamu Mori, Takashi Yokochi, Yoshinobu Kimura

Original Investigation

Dietary intake of Lactobacillus rhamnosus HN001 enhances production of both Th1 and Th2 cytokines in antigen-primed mice

Martin L. Cross, Rikke R. Mortensen, Jane Kudsk, Harsharnjit S. Gill

Original Investigation

Invasion of HeLa cells by Enterococcus faecalis clinical isolates

Lucia Bertuccini, Maria Ammendolia, Fabiana Superti, Lucilla Baldassarri

Original Investigation

Cultivation at 37°C enhances Borrelia burgdorferi sensu stricto infectivity for hamsters

Marygorret Obonyo, Ulrike G. Munderloh, Thien N. Sam, Timothy J. Kurtti

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine